Vanda Pharmaceuticals
VNDA
#8435
Rank
$0.31 B
Marketcap
$5.25
Share price
-1.50%
Change (1 day)
16.41%
Change (1 year)

Vanda Pharmaceuticals (VNDA) Fails to deliver data

Key failure to deliver metrics for Vanda Pharmaceuticals:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Vanda Pharmaceuticals (VNDA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Vanda Pharmaceuticals (VNDA) - since 2013

Volume in USD (price x number of shares), data since 2013

Vanda Pharmaceuticals (VNDA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026$1.07 M-25.72%
2025$1.44 M36.93%
2024$1.05 M-46.53%
2023$1.98 M25.12%
2022$1.58 M-83.12%
2021$9.37 M250.19%
2020$2.67 M10.49%
2019$2.42 M-79.15%
2018$11.62 M291.09%
2017$2.97 M-11.3%
2016$3.34 M-92.37%
2015$43.92 M14.93%
2014$38.22 M381.32%
2013$7.94 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
$0.23 B$0.39 B๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$36.12 M$0.42 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$0.19 B$0.33 B๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$78.57 M$0.46 B๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$33.25 M$0.21 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$26.31 M$81.8 M๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
N/A$0.09 M๐Ÿ‡บ๐Ÿ‡ธ USA